title: Neoadjuvant treatment of rectal cancer: where are we now?
authors.affiliation: Developmental Therapeutics Program of Division of Hematology & Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL USA Division of Hematology & Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL USA Aparna.kalyan@northwestern.edu.
authors.forename: Aparna
authors.initials: A
authors.lastname: Kalyan
authors.affiliation: Division of Hematology & Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL USA.
authors.forename: Shaina
authors.initials: S
authors.lastname: Rozelle
authors.affiliation: Division of Hematology & Oncology, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL USA.
authors.forename: Al
authors.initials: A
authors.lastname: Benson
keywords: 5-fluorouracil; local recurrence; neoadjuvant chemoradiation; rectal cancer